https://pendopharm.beauvoir.dev/news/ 2025-12-01T18:51:50+00:00 https://pendopharm.beauvoir.dev/news/pendopharm-launches-a-new-alcohol-free-formulation-of-its-product-pharixia/ 2022-06-17T13:59:32+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-lance-une-nouvelle-formulation-de-son-produit-pharixia-sans-alcool/ 2022-06-17T14:00:47+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/la-solution-orale-prpdp-levetiracetam-100-mg-ml-maintenant-offerte-au-canada/ 2022-06-17T15:21:14+00:00 https://pendopharm.beauvoir.dev/news/prpdp-levetiracetam-oral-solution-100-mg-ml-now-available-in-canada/ 2022-06-17T15:24:22+00:00 https://pendopharm.beauvoir.dev/news/pharmascience-inc-introduces-prpdp-levetiracetam-an-antiepileptic-injection-solution-to-its-pediatric-medicine-line/ 2022-06-17T15:39:00+00:00 https://pendopharm.beauvoir.dev/wp-content/uploads/2022/06/image-615x900-levetiracetam.jpeg https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-lance-la-solution-orale-de-prpdp-amlodipine-pour-le-traitement-de-lhypertension-chez-les-enfants/ 2022-06-17T15:51:17+00:00 https://pendopharm.beauvoir.dev/wp-content/uploads/2022/06/photo-key-product-pdp-amlodipine-430x715-352x585-1.png https://pendopharm.beauvoir.dev/news/pendopharm-launches-prpdp-amlodipine-oral-solution-for-the-treatment-of-hypertension-in-children/ 2022-06-17T15:52:19+00:00 https://pendopharm.beauvoir.dev/wp-content/uploads/2022/06/photo-key-product-pdp-amlodipine-430x715-352x585-1.png https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-une-division-de-pharmascience-inc-remporte-le-prix-d-w-bole/ 2022-06-19T20:59:45+00:00 https://pendopharm.beauvoir.dev/wp-content/uploads/2022/06/d_w_-bole-pendopharm.jpeg https://pendopharm.beauvoir.dev/news/pendopharm-a-division-of-pharmascience-inc-wins-the-d-w-bole-award/ 2022-06-19T20:59:47+00:00 https://pendopharm.beauvoir.dev/wp-content/uploads/2022/06/d_w_-bole-pendopharm.jpeg https://pendopharm.beauvoir.dev/news/pendopharm-launches-glatect-a-new-treatment-option-for-ms-patients/ 2022-06-19T21:12:08+00:00 https://pendopharm.beauvoir.dev/news/pendopharm-a-division-of-pharmascience-inc-invests-in-ontario-based-edesa-biotech-and-licenses-three-novel-anorectal-treatments-for-canada/ 2022-06-19T21:17:11+00:00 https://pendopharm.beauvoir.dev/news/pendopharm-to-promote-entocort-budesonide-within-canada-for-tillotts-pharma-ag/ 2022-06-19T21:21:00+00:00 https://pendopharm.beauvoir.dev/wp-content/uploads/2022/06/entocort-capsules.jpeg https://pendopharm.beauvoir.dev/news/health-canadas-approval-of-ibavyr/ 2022-06-19T21:31:51+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-lance-glatect-une-nouvelle-option-de-traitement-pour-les-patients-atteints-de-sp/ 2022-06-19T21:35:06+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pharmascience-inc-lance-prpdp-levetiracetam-un-antiepileptique-en-solution-pour-injection-qui-vient-sajouter-a-sa-gamme-de-medicaments-pediatriques/ 2022-06-19T21:35:45+00:00 https://pendopharm.beauvoir.dev/wp-content/uploads/2022/06/image-615x900-levetiracetam.jpeg https://pendopharm.beauvoir.dev/fr/nouvelles/approbation-dibavyrmc-par-sante-canada/ 2022-06-19T21:46:39+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-une-division-de-pharmascience-signe-une-entente-avec-cosmo-pharmaceuticals/ 2022-06-19T21:46:51+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-fera-la-promotion-de-entocortmd-budesonide-au-canada-pour-le-compte-de-tillotts-pharma-ag/ 2022-06-19T21:47:12+00:00 https://pendopharm.beauvoir.dev/wp-content/uploads/2022/06/entocort-capsules.jpeg https://pendopharm.beauvoir.dev/news/pendopharm-a-division-of-pharmascience-signs-an-agreement-with-cosmo-pharmaceuticals/ 2022-06-19T21:51:17+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/nomination-de-morris-goodman-co-fondateur-et-president-du-conseil-dadministration-de-pharmascience-inc-au-sein-de-lordre-du-canada/ 2022-06-29T18:08:53+00:00 https://pendopharm.beauvoir.dev/wp-content/uploads/2022/06/morris-682x1024-1.jpeg https://pendopharm.beauvoir.dev/fr/nouvelles/pharmascience-inc-selectionnee-au-palmares-des-meilleurs-employeurs-au-canada-selon-forbes-pour-2020/ 2022-06-30T12:41:33+00:00 https://pendopharm.beauvoir.dev/wp-content/uploads/2022/06/forbes-2020-982x581f-768x454-1.jpeg https://pendopharm.beauvoir.dev/news/morris-goodman-co-founder-and-chairman-of-the-board-of-pharmascience-inc-is-appointed-to-the-order-of-canada/ 2022-06-30T12:48:12+00:00 https://pendopharm.beauvoir.dev/wp-content/uploads/2022/06/morris-682x1024-1.jpeg https://pendopharm.beauvoir.dev/fr/nouvelles/pharmascience-inc-contribue-au-colchicine-cardiovascular-outcome-trial-colcot-de-linstitut-de-cardiologie-de-montreal/ 2022-06-30T12:51:24+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pharmascience-inc-reconnue-une-fois-de-plus-parmi-les-meilleurs-employeurs/ 2022-06-30T13:19:46+00:00 https://pendopharm.beauvoir.dev/wp-content/uploads/2022/06/montreal-top2020-982x615f-300x188-1.jpeg https://pendopharm.beauvoir.dev/news/pharmascience-inc-recognized-once-again-as-top-employer/ 2022-06-30T13:21:59+00:00 https://pendopharm.beauvoir.dev/wp-content/uploads/2022/06/montreal-top2020-982x615e-300x188-1.jpeg https://pendopharm.beauvoir.dev/news/pharmascience-inc-makes-2020-forbes-list-of-canadas-best-employers/ 2022-07-06T12:38:31+00:00 https://pendopharm.beauvoir.dev/wp-content/uploads/2022/06/forbes-2020-982x581e-300x177-1.jpeg https://pendopharm.beauvoir.dev/news/pharmascience-inc-contributes-to-the-montreal-heart-institutes-colchicine-cardiovascular-outcome-trial-colcot/ 2022-07-06T12:39:08+00:00 https://pendopharm.beauvoir.dev/news/health-canada-approves-myinflatm-colchicine-0-5-mg-extended-release-tablets-a-new-repurposed-treatment-for-cardiovascular-disease/ 2022-07-20T18:13:27+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/sante-canada-approuve-myinflamc-comprimes-de-colchicine-05-mg-a-liberation-prolongee-un-nouveau-traitement-repositionne-pour-les-maladies-cardiovasculaires/ 2022-07-20T18:13:38+00:00 https://pendopharm.beauvoir.dev/news/canadian-football-league-brings-attention-to-player-health-through-multi-year-marketing-partnership-with-monovisc/ 2022-07-27T14:15:11+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/la-ligue-canadienne-de-football-porte-une-attention-a-la-sante-de-ses-joueurs-grace-a-un-partenariat-de-plusieurs-annees-avec-monoviscmd%ef%bf%bc/ 2022-07-27T14:19:07+00:00 https://pendopharm.beauvoir.dev/news/glatecttm-is-now-covered-by-the-provincial-drug-plan-in-british-columbia-for-the-treatment-of-relapsing-remitting-multiple-sclerosis-rrms/ 2022-07-27T14:22:07+00:00 https://pendopharm.beauvoir.dev/news/pendopharm-launches-eleviewtm-in-canada-submucosal-injectable-composition-10ml/ 2022-07-27T14:24:04+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-lance-eleviewmc-au-canada-composition-injectable-sous-muqueuse-10ml/ 2022-07-27T14:27:27+00:00 https://pendopharm.beauvoir.dev/news/pendopharm-is-proud-to-launch-an-alcohol-free-antigingivitis-oral-rinse/ 2022-08-02T14:51:35+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-est-fiere-de-lancer-un-rince-bouche-contre-la-gingivite-sans-alcool/ 2022-08-02T14:53:44+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-une-division-de-pharmascience-inc-est-fiere-de-lancer-sportvismc-pour-soulager-la-douleur-et-restaurer-la-fonction-des-tendons-et-des-ligaments-leses/ 2022-08-25T21:26:34+00:00 https://pendopharm.beauvoir.dev/news/pendopharm-a-division-of-pharmascience-inc-is-proud-to-launch-sportvistm-to-relieve-pain-and-restore-function-in-damaged-tendons-and-ligaments/ 2022-08-25T21:28:07+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-annonce-le-lancement-doctasamd-a-800-mg-au-canada/ 2022-11-14T22:50:45+00:00 https://pendopharm.beauvoir.dev/news/pendopharm-announces-the-launch-of-octasa-800-mg-tablets-in-canada/ 2022-11-14T22:51:12+00:00 https://pendopharm.beauvoir.dev/news/pendopharm-announces-the-launch-of-octasa-1600-mg-tablets-in-canada/ 2023-04-11T15:59:02+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-annonce-le-lancement-doctasamd-a-1600-mg-au-canada/ 2023-04-11T16:01:22+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-remporte-des-honneurs-grace-a-cingal/ 2023-05-09T18:31:01+00:00 https://pendopharm.beauvoir.dev/news/pendopharm-receives-honours-thanks-to-cingal/ 2023-05-09T18:32:05+00:00 https://pendopharm.beauvoir.dev/news/pendopharm-renews-distribution-agreement-with-anika-therapeutics-inc-for-cingal-monovisc-and-orthovisc/ 2024-05-16T15:47:25+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-renouvelle-son-partenariat-de-commercialisation-avec-anika-therapeutics-inc-pour-les-produits-cingalmd-monoviscmd-et-orthoviscmd/ 2024-05-16T16:04:01+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-signe-une-entente-de-distribution-exclusive-avec-ascendis-pharma-a-s-pour-transcon-mc-pth-au-canada/ 2024-07-10T14:08:24+00:00 https://pendopharm.beauvoir.dev/news/pendopharm-signs-exclusive-distribution-agreement-with-ascendis-pharma-a-s-for-transcon-pth-in-canada/ 2024-07-10T14:09:50+00:00 https://pendopharm.beauvoir.dev/news/pendopharm-announces-public-drug-coverage-plan-listings-for-octasa-oral-mesalamine/ 2025-03-11T20:45:50+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/glatectmc-maintenant-couvert-par-le-regime-dassurance-medicaments-de-la-colombie-britannique-pour-le-traitement-de-la-sclerose-en-plaque-sp-remittente/ 2025-03-11T21:10:35+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-et-kalvista-sassocient-pour-introduire-au-canada-le-tout-premier-traitement-oral-a-la-demande-contre-laoh/ 2025-06-26T21:57:43+00:00 https://pendopharm.beauvoir.dev/news/pendopharm-and-kalvista-partner-to-bring-first-oral-on-demand-hae-treatment-to-canada/ 2025-06-26T21:57:57+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-annonce-le-remboursement-provincial-doctasamd-mesalamine-orale/ 2025-07-29T15:28:05+00:00 https://pendopharm.beauvoir.dev/news/pendopharmmd-signe-un-accord-de-distribution-exclusif-avec-neuraxpharm-pour-prbuccolammd-au-canada-et-annonce-son-approbation-par-sante-canada/ 2025-12-01T18:51:40+00:00 https://pendopharm.beauvoir.dev/fr/nouvelles/pendopharm-signs-an-exclusive-distribution-agreement-with-neuraxpharm-for-prbuccolam-in-canada-and-announces-its-approval-by-health-canada/ 2025-12-01T18:51:50+00:00